P
Pulse Biosciences, Inc.
PLSE · NASDAQ · Healthcare · 3.1B
Closing price
$53.81
+7.66% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
45.0×
Enterprise value / EBITDAEV/EBITDA
-49.6×
Free cash flow yieldFCF yield
-1.5%
Return on equityROE
-90.2%
Operating margin
-21982.6%
Net debt / EBITDAbalance-sheet strength
1.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.